Representations of Transplantation in Patients and in Health Care Professionals
NCT ID: NCT01285882
Last Updated: 2015-04-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
14 participants
OBSERVATIONAL
2009-06-30
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Specific objectives :
1. Identify the knowledge, representations, or feelings of patients which could constitute bridles or factors of motivation to use for transplantation.
2. Identify the knowledge, representations, or feelings of medical persons which could constitute bridles or factors of motivation to the "encouraging" proposal to patients of lung transplant.
3. Identify the knowledge, representations, or feelings of assistants which could constitute bridles or factors of motivation to the "encouragement" of lung transplantation at its close.
4. Identify the needs of patients, assistants and medical persons to successfully reduce these bridles to transplantation and increase the factors of motivation.
5. Compare the representations of patients, assistants and medical persons
6. Search representations associated with patients who refuse the transplantation and those who accept the transplantation
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feeding Behavior and Taste Sensitivity Before and After Liver or Renal Transplantation
NCT02931812
Acute and Chronic Pain in Lung Transplantation: Prevalence, Associated Factors, Taken Care
NCT02897882
Is Access to Liver Transplantation Similar in Alcoholic or Not Patients?
NCT01820819
Evaluation of a New Regional Organization to Promote Access to Renal Transplantation
NCT03234075
Assessment of Lung Transplant Recipients Within The Scope of International Classification of Functioning, Disability and Health
NCT05376605
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Representations
Representations
1. A pre-test with 5 medical persons and 5 persons without mucoviscidosis will be realized to adjust the tools and place of the interview.
2. To collect analyzable data for 30 patients, 40 patients will be included in the study. A conceptual card will be associated to a semi-structured interviews to gather information.Two subgroups will be considered in th a analysis :
* 1st sub-group : After the announcement of the transplant indication by the doctor and before the consultation in the transplant centre.
* 2nd subgroup : After the consultation in the transplant centre but before the inscription on the waiting list. The analysis of conceptual cards in these two subgroups will permit to study the differences between the representations of patients before and after the consultation in the transplant centre.
3. Realize a 2nd interview on the same principle with all patients, 1 year after their lung transplantation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Representations
1. A pre-test with 5 medical persons and 5 persons without mucoviscidosis will be realized to adjust the tools and place of the interview.
2. To collect analyzable data for 30 patients, 40 patients will be included in the study. A conceptual card will be associated to a semi-structured interviews to gather information.Two subgroups will be considered in th a analysis :
* 1st sub-group : After the announcement of the transplant indication by the doctor and before the consultation in the transplant centre.
* 2nd subgroup : After the consultation in the transplant centre but before the inscription on the waiting list. The analysis of conceptual cards in these two subgroups will permit to study the differences between the representations of patients before and after the consultation in the transplant centre.
3. Realize a 2nd interview on the same principle with all patients, 1 year after their lung transplantation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult patient (those concerned by the suggestion of lung transplant).
* At the time of transplant indication : after the first suggestion of the medical person, before or after the preoperative graft check-up but before registration on waiting list.
* For medical persons :
* Medical persons involved in the suggestion of lung transplantation to the patients.
* For assistants :
* Adult close to the patient and that the patient sees as a resource person and advisor in his choices for the transplant : reference person having a major influence for the patient (spouse, parent, sibling, friend ...)
Exclusion Criteria
* Patient with a psychiatric disorder
* Patient in intensive care unit
* Palliative care patient
* Patient aged under 18 years old
* Patient refusal
* For medical persons :
* Medical person refusal
* For assistants :
* Assistant or patient refusal
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nantes University Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Valérie DAVID, Doctor
Role: PRINCIPAL_INVESTIGATOR
Nantes University Hospital
Raphaële NOVE-JOSSERAND, Doctor
Role: STUDY_CHAIR
Hospices Civils de Lyon
Marc STERN, Profesor
Role: STUDY_CHAIR
Hôpital Foch
Martine REYNAUD-GAUBERT, Profesor
Role: STUDY_CHAIR
CHU de Marseille
Isabelle DURIEU, Doctor
Role: STUDY_CHAIR
Hospices Civils de Lyon
Dominique HUBERT, Doctor
Role: STUDY_CHAIR
Hôpital Cochin
Sophie RAMEL, Doctor
Role: STUDY_CHAIR
Centre de Perharidy - Roscoff
RAVONINJATOVO, Doctor
Role: STUDY_CHAIR
CHU de Reims
Magali DUPUY-GRASSET, Doctor
Role: STUDY_CHAIR
University Hospital, Limoges
Céline MENETREY, Doctor
Role: STUDY_CHAIR
University Hospital, Limoges
Chantal BELLEGUIC, Doctor
Role: STUDY_CHAIR
Rennes University Hospital
Corina SANZIANA CORHUT, Doctor
Role: STUDY_CHAIR
Central Hospital, Nancy, France
Benoît GODBERT, Doctor
Role: STUDY_CHAIR
Central Hospital, Nancy, France
Françoise VARAIGNE, Doctor
Role: STUDY_CHAIR
CHU de Tours
Isabelle PIN, Doctor
Role: STUDY_CHAIR
University Hospital, Grenoble
Marie-Laure UFFREDI, Doctor
Role: STUDY_CHAIR
CH de Vannes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nantes University Hospital
Nantes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PROG/10/89
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.